Smith Anglin Financial’s Cognition Therapeutics CGTX Stock Holding History

Smith Anglin Financial’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.72K	Hold	12,000	–	–	﹤0.01%	209
2025 Q1	$5.05K	Hold	12,000	–	–	﹤0.01%	213
2024 Q4	$8.42K	Hold	12,000	–	–	﹤0.01%	213
2024 Q3	$5.62K	Hold	12,000	–	–	﹤0.01%	207
2024 Q2	$19.9K	Hold	12,000	–	–	﹤0.01%	195
2024 Q1	$21.8K	Hold	12,000	–	–	﹤0.01%	198
2023 Q4	$22.2K	Buy	+12,000	New	+$15.9K	﹤0.01%	182

Other funds holding CGTX

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return